Childrens Hospital of Philadelphia — Philadelphia, Pennsylvania

Public research footprint of Childrens Hospital of Philadelphia, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Spinal Muscular Atrophy · Sickle Cell Disease · Suicide · Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Recently updated registry entries

NCT07005232 — Lead Evaluation for Defibrillation and Reliability Post Approval Study (Enrolling By Invitation)
NCT05265273 — A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized… (Recruiting)
NCT04175600 — A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Childrens Hospital of Philadelphia?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.